{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:59:34Z","timestamp":1787162374503,"version":"build-2736575974"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.japh.2025.102474","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T03:30:24Z","timestamp":1751427024000},"page":"102474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Tirzepatide associated autoimmune encephalitis: A case report"],"prefix":"10.1016","volume":"65","author":[{"given":"Asad","family":"Abdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Ariaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helia","family":"Hemasian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahab","family":"Shahabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzad","family":"Sina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.japh.2025.102474_bib1","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2174\/1871527319666200708133103","article-title":"Autoimmune encephalitis: current knowledge on subtypes, disease mechanisms and treatment","volume":"19","author":"Nissen","year":"2020","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"1","key":"10.1016\/j.japh.2025.102474_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3988\/jcn.2016.12.1.1","article-title":"The diagnosis and treatment of autoimmune encephalitis","volume":"12","author":"Lancaster","year":"2016","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.japh.2025.102474_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2147\/IJGM.S397429","article-title":"Anti-NMDA receptor autoimmune encephalitis: diagnosis and management strategies","volume":"16","author":"Nguyen","year":"2023","journal-title":"Int J Gen Med"},{"issue":"4","key":"10.1016\/j.japh.2025.102474_bib4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.japh.2025.102474_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/jalm\/jfab106","article-title":"Retrospective evaluation of the antibody prevalence in epilepsy and encephalopathy (APE2) score","volume":"7","author":"Poore","year":"2022","journal-title":"J Appl Lab Med"},{"issue":"2","key":"10.1016\/j.japh.2025.102474_bib6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1210\/clinem\/dgaa863","article-title":"Dual GIP and GLP-1 receptor agonist tirzepatide improves beta-cell function and insulin sensitivity in type 2 diabetes","volume":"106","author":"Thomas","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.japh.2025.102474_bib7","article-title":"GLP\u2212 1 receptor agonists for the treatment of obesity: role as a promising approach","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.japh.2025.102474_bib8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s13300-020-00981-0","article-title":"The role of tirzepatide, dual GIP and GLP-1 receptor agonist, in the management of type 2 diabetes: the SURPASS clinical trials","volume":"12","author":"Min","year":"2021","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.japh.2025.102474_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neuroimage.2015.04.042","article-title":"A computational atlas of the hippocampal formation using ex vivo, ultra-high resolution MRI: application to adaptive segmentation of in vivo MRI","volume":"115","author":"Iglesias","year":"2015","journal-title":"Neuroimage"},{"key":"10.1016\/j.japh.2025.102474_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giae049","article-title":"CAT: a computational anatomy toolbox for the analysis of structural MRI data","volume":"13","author":"Gaser","year":"2024","journal-title":"Gigascience"},{"key":"10.1016\/j.japh.2025.102474_bib11","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3389\/fphar.2016.00433","article-title":"Glucagon-like peptide-1 analog, liraglutide, delays onset of experimental autoimmune encephalitis in lewis rats","volume":"7","author":"DellaValle","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.japh.2025.102474_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2023.114348","article-title":"Activation of glucagon-like peptide-1 receptor in microglia exerts protective effects against sepsis-induced encephalopathy via attenuating endoplasmic reticulum stress-associated inflammation and apoptosis in a mouse model of sepsis","volume":"363","author":"Yi","year":"2023","journal-title":"Exp Neurol"},{"issue":"3","key":"10.1016\/j.japh.2025.102474_bib13","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1007\/s13311-021-01088-5","article-title":"Therapeutic potential of a novel glucagon-like peptide-1 receptor agonist, NLY01, in experimental autoimmune encephalomyelitis","volume":"18","author":"Gharagozloo","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"3","key":"10.1016\/j.japh.2025.102474_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/jamaophthalmol.2024.6058","article-title":"Ophthalmic complications associated with the antidiabetic drugs semaglutide and tirzepatide","volume":"143","author":"Katz","year":"2025","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.japh.2025.102474_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.cdnut.2024.102316","article-title":"A case of compounded tirzepatide-induced psychiatric adverse effects","volume":"8","author":"Bobbs","year":"2024","journal-title":"Curr Dev Nutr"},{"issue":"2","key":"10.1016\/j.japh.2025.102474_bib16","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s11096-023-01694-7","article-title":"Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database","volume":"46","author":"Tobaiqy","year":"2024","journal-title":"Int J Clin Pharm"},{"issue":"3","key":"10.1016\/j.japh.2025.102474_bib17","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00415-021-10785-2","article-title":"Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature","volume":"269","author":"Khan","year":"2022","journal-title":"J Neurol"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319125001530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319125001530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T07:18:00Z","timestamp":1777015080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319125001530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1544319125001530"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2025.102474","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tirzepatide associated autoimmune encephalitis: A case report","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2025.102474","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102474"}}